Evidence map›Paper›PMID 23229731›Full record

ArticleInternational journal of obesity (2005)2013

Energy expenditure in obese children with pseudohypoparathyroidism type 1a.

A H Shoemaker, J P Lomenick, B R Saville, W Wang, M S Buchowski, R D Cone

3 registry-linked trialsAbstract read
In one paragraph

Article in International journal of obesity (2005), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02411461 completednot on this mapstarted 2014, after this paper: background citation

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

TypeobservationalSponsorVanderbilt University Medical CenterRan2014 to 2017Enrolled39ConditionsPseudohypoparathyroidism, Albright Hereditary Osteodystrophy
NCT02463409 phase2completednot on this mapstarted 2015, after this paper: background citation

Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a

TypeinterventionalSponsorVanderbilt University Medical CenterRan2015 to 2016Enrolled6ConditionsPseudohypoparathyroidism Type 1a, Albright Hereditary OsteodystrophyArmsTheophylline
NCT03029429 phase2active not recruitingnot on this mapstarted 2018, after this paper: background citation

Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism

TypeinterventionalSponsorVanderbilt University Medical CenterRan2018 to 2026Enrolled29ConditionsPseudohypoparathyroidism, Albright Hereditary OsteodystrophyArmsTheophylline, Placebos
3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. A Novel Maternally InheritedJCEM case reports · 2024
    Article
  5. Observational
  6. Review
  7. Review
  8. Management of pseudohypoparathyroidism.Current opinion in pediatrics · 2019
    Review
  9. Thyroid Hormone Action and Energy Expenditure.Journal of the Endocrine Society · 2019
    Review
  10. Pseudohypoparathyroidism.Endocrinology and metabolism clinics of North America · 2018
    Review
  11. Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism.The Journal of clinical endocrinology and metabolism · 2018
    Article
  12. Review
  13. Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Nonclassic features of pseudohypoparathyroidism type 1A.Current opinion in endocrinology, diabetes, and obesity · 2017
    Review
  18. Article
  19. Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A.The Journal of clinical endocrinology and metabolism · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A H ShoemakerDivision of Pediatric Endocrinology, Vanderbilt Children's Hospital, Nashville, TN 37232, USA. ashley.h.shoemaker@vanderbilt.edu
J P Lomenick
B R Saville
W Wang
M S Buchowski
R D Cone

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
Melanocortin Signaling in Feeding BehaviorR01DK070332 · NIDDK · VANDERBILT UNIVERSITY · PI CONE, ROGER D. · 2004 to 2017
$6.1M
Conducting Child Health Care Research in Vulnerable PopulationsT32HD060554 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BARKIN, SHARI, WILLIAMS, DEREK J. · 2009 to 2019
$3.8M
NCRR NIH HHS 5 M01 RR-000095NCRR NIH HHS M01 RR000095NCRR NIH HHS UL1 RR024975NCRR NIH HHS URL1 RR024975-01NICHD NIH HHS 5T32 HD 060554-02NICHD NIH HHS T32 HD060554NIDDK NIH HHS R01 DK 070332NIDDK NIH HHS R01 DK070332
6 · The paper itself

Abstract

contextPatients with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. The abnormality in energy expenditure and/or energy intake responsible for this weight gain is unknown.

objectiveThe aim of this study was to evaluate energy expenditure in children with PHP-1a compared with obese controls. PATIENTS: We studied 6 obese females with PHP-1a and 17 obese female controls. Patients were recruited from a single academic center. MEASUREMENTS: Resting energy expenditure (REE) and thermogenic effect of a high fat meal were measured using whole room indirect calorimetry. Body composition was assessed using whole body dual energy x-ray absorptiometry. Fasting glucose, insulin, and hemoglobin A1C were measured.

resultsChildren with PHP-1a had decreased REE compared with obese controls (P<0.01). After adjustment for fat-free mass, the PHP-1a group's REE was 346.4 kcals day(-1) less than obese controls (95% CI (-585.5--106.9), P<0.01). The thermogenic effect of food (TEF), expressed as percent increase in postprandial energy expenditure over REE, was lower in PHP-1a patients than obese controls, but did not reach statistical significance (absolute reduction of 5.9%, 95% CI (-12.2-0.3%), P=0.06).

conclusionsOur data indicate that children with PHP-1a have decreased REE compared with the obese controls, and that may contribute to the development of obesity in these children. These patients may also have abnormal diet-induced thermogenesis in response to a high-fat meal. Understanding the causes of obesity in PHP-1a may allow for targeted nutritional or pharmacologic treatments in the future.

Indexed as

Weight GainAbsorptiometry, PhotonAdolescentAge of OnsetBasal MetabolismBlood GlucoseBody CompositionCalorimetry, IndirectChildDisease SusceptibilityEnergy MetabolismFemaleGlycated HemoglobinHumansInsulinPediatric ObesityBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanInsulin

Identifiers

PMID23229731
PMCPMC3610772

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.